Loading...
Pfizer Inc. Delivers Resilient Q3 and 9M 2025 Performance with Strong EPS Outperformance, Cost Discipline and Strategic Repositioning
n/a
n/a
Wane_Investment_House's Fair Value
n/a
1Y
-1.7%7D
0%1Y
-1.7%7D
0%You can edit this narrative until Jan 5 1:00 PM. Then, changes will post as Updates.